SEC Form 4 · accession 0001062993-18-004216
Orgenesis Inc. · ORGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Sarah Ferber
Officer — Chief Scientific Officer
Period of report
Oct 22, 2018
Accepted (ET)
Oct 25, 2018 · 9:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001460602
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $5.99 | Oct 22, 2018 | A | 3,750 | A | — | Oct 22, 2018 | Common Stock | 3,750 | 3,750 | D |
Explanation of responses
- F1These options were awarded under the Issuer's 2017 Equity Incentive Plan to purchase shares of common stock of the Issuer and vest in equal quarterly installments over a four-year period beginning January 22, 2019.